Kymera Therapeutics (KYMR) PT Raised to $36 at B.Riley
Tweet Send to a Friend
(Updated - July 9, 2024 7:35 AM EDT)
B.Riley analyst Kalpit Patel raised the price target on Kymera Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
B.Riley analyst Kalpit Patel raised the price target on Kymera Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
